Efficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: rationale and design of a randomized controlled trial

BMC Psychiatry

Yves de Roten¹  Martin Preisig²  Jean-Nicolas Despland¹  Gilles Ambresin¹ 

[1]Department of Psychiatry-CHUV, Centre for Psychotherapy Research, University Institute of Psychotherapy, The University of Lausanne, Av. de Morges 10, CH-1004, Lausanne, Switzerland

[2]Department of Psychiatry-CHUV, Centre for Psychiatry Epidemiology and Psychopathology, The University of Lausanne, Lausanne, Switzerland

关键词: Therapeutic alliance;    Randomized controlled trial;    Psychoanalytic psychotherapy;    Inpatient;    Unipolar depression;   

Others  :  1124250
DOI  :  10.1186/1471-244X-12-182

 received in 2012-08-17, accepted in 2012-10-26,  发布年份 2012

【 摘 要 】

Background

A few recent studies have found indications of the effectiveness of inpatient psychotherapy for depression, usually of an extended duration. However, there is a lack of controlled studies in this area and to date no study of adequate quality on brief psychodynamic psychotherapy for depression during short inpatient stay exists. The present article describes the protocol of a study that will examine the relative efficacy, the cost-effectiveness and the cost-utility of adding an Inpatient Brief Psychodynamic Psychotherapy to pharmacotherapy and treatment-as-usual for inpatients with unipolar depression.

Methods/Design

The study is a one-month randomized controlled trial with a two parallel group design and a 12-month naturalistic follow-up. A sample of 130 consecutive adult inpatients with unipolar depression and Montgomery-Asberg Depression Rating Scale score over 18 will be recruited. The study is carried out in the university hospital section for mood disorders in Lausanne, Switzerland. Patients are assessed upon admission, and at 1-, 3- and 12- month follow-ups. Inpatient therapy is a manualized brief intervention, combining the virtues of inpatient setting and of time-limited dynamic therapies (focal orientation, fixed duration, resource-oriented interventions). Treatment-as-usual represents the best level of practice for a minimal treatment condition usually proposed to inpatients. Final analyses will follow an intention–to-treat strategy. Depressive symptomatology is the primary outcome and secondary outcome includes measures of psychiatric symptomatology, psychosocial role functioning, and psychodynamic-emotional functioning. The mediating role of the therapeutic alliance is also examined. Allocation to treatment groups uses a stratified block randomization method with permuted block. To guarantee allocation concealment, randomization is done by an independent researcher.

Discussion

Despite the large number of studies on treatment of depression, there is a clear lack of controlled research in inpatient psychotherapy during the acute phase of a major depressive episode. Research on brief therapy is important to take into account current short lengths of stay in psychiatry. The current study has the potential to scientifically inform appropriate inpatient treatment. This study is the first to address the issue of the economic evaluation of inpatient psychotherapy.

Trial registration

Australian New Zealand Clinical Trial Registry (ACTRN12612000909820)

【 授权许可】

   
2012 Ambresin et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]WHO: The global burden of disease: 2004 update. Geneva: World Health Organization; 2008.
• [2]APA: Practice guideline for the treatment of patients with major depressive disorder. 3rd edition. Arlington (VA): American Psychiatric Association; 2010.
• [3]NICE: Depression: the treatment and management of depression in adults (update). London: National Institute for Health and Clinical Excellence; 2009.
• [4]Priebe S, McCabe R, Schuetzwohl M, Kiejna A, Nawka P, Raboch J, Reininghaus U, Wang D, Kallert TW: Patient characteristics predicting better treatment outcomes in day hospitals compared with inpatient wards. Psychiatr Serv 2011, 62(3):278-284.
• [5]Lauber C, Lay B, Roessler W: Length of first admission and treatment outcome in patients with unipolar depression. J Affect Disord 2006, 93:43-51.
• [6]Schramm E, van Calker D, Dykierek P, Lieb K, Kech S, Zobel I, Leonhart R, Berger M: An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results. Am J Psychiatry 2007, 164(5):768-777.
• [7]Lelliott P: Acute inpatient psychiatry in England: an old problem and a new priority. Epidemiol Psichiatr Soc 2006, 15(2):91-94.
• [8]Seemueller F, Riedel M, Obermeier M, Bauer M, Adli M, Kronmueller K, Holsboer F, Brieger P, Laux G, Bender W, et al.: Outcomes of 1014 naturalistically treated inpatients with major depressive episode. Eur Neuropsychopharmacol 2010, 20(5):346-355.
• [9]Riedel M, Mueller H-J, Obermeier M, Adli M, Bauer M, Kronmueller K, Brieger P, Laux G, Bender W, Heuser I, et al.: Clinical predictors of response and remission in inpatients with depressive syndromes. J Affect Disord 2011, 133(1-2):137-149.
• [10]Schneider F, Harter M, Brand S, Sitta P, Menke R, Hammer-Filipiak U, Kudling R, Heindl A, Herold K, Frommberger U, et al.: Adherence to guidelines for treatment of depression in in-patients. Br J Psychiatry 2005, 187:462-469.
• [11]Jakobsen JC, Hansen JL, Simonsen E, Gluud C: The effect of adding psychodynamic therapy to antidepressants in patients with major depressive disorder. A systematic review of randomized clinical trials with meta-analyses and trial sequential analyses. J Affect Disord 2012, 137(1-3):4-14.
• [12]de Maat SM, Dekker J, Schoevers RA, De Jonghe F: Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis. Eur Psychiatry 2007, 22:1-8.
• [13]Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O'Reardon JP, Lovett ML, Young PR, Haman KL, Freeman BB, et al.: Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 2005, 62(4):417-422.
• [14]Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C: Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 2004, 61(7):714-719.
• [15]Vittengl JR, Clark LA, Dunn TW, Jarrett RB: Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. J Consult Clin Psychol 2007, 75(3):475-488.
• [16]Huber TJ: Stationäre depressionsbehandlung. Soll man Psychotherapie und Medikamente kombinieren? Der Nervenarzt 2005, 76(3):270-277.
• [17]Driessen E, Cuijpers P, de Maat SCM, Abbass AA, de Jonghe F, Dekker JJM: The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis. Clin Psychol Rev 2010, 30(1):25-36.
• [18]de Maat S, Dekker J, Schoevers R, van Aalst G, Gijsbers-van Wijk C, Hendriksen M, Kool S, Peen J, Van R, de Jonghe F: Short psychodynamic supportive psychotherapy, antidepressants, and their combination in the treatment of major depression: a mega-analysis based on three randomized clinical trials. Depress Anxiety 2008, 25(7):565-574.
• [19]Leichsenring F: Comparative effects of short-term psychodynamic psychotherapy and cognitive-behavioral therapy in depression: a meta-analytic approach. Clin Psychol Rev 2001, 21(3):401-419.
• [20]Franz M, Janssen P, Lensche H, Schmidtke V, Tetzlaff M, Martin K, Wöller W, Hartkamp N, Schneider G, Heuft G: Effekte stationärer psychoanalytisch orientierter Psychotherapie - eine Multizenterstudie. Z Psychosom Med 2000, 46:242-258.
• [21]Beutel ME, Hoeflich A, Kurth R, Brosig B, Gieler U, Leweke F, Milch WE, Reimer C: Stationare Kurz- und Langzeitpsychotherapie – Indikationen, Ergebnisse, Pradiktoren. Z Psychosom Med Psychoanal 2005, 51(2):145-162.
• [22]Schramm E, Schneider D, Zobel I, van Calker D, Dykierek P, Kech S, Harter M, Berger M: Efficacy of interpersonal psychotherapy plus pharmacotherapy in chronically depressed inpatients. J Affect Disord 2008, 109(1–2):65-73.
• [23]Hansen NB, Lambert MJ, Forman EM: The psychotherapy dose–response effect and its implications for treatment delivery services. Clin Psychol Sci Pract 2002, 9(3):329-343.
• [24]Barkham M, Rees A, Stiles WB, Shapiro DA, Hardy GE, Reynolds S: Dose-effect relations in time-limited psychotherapy for depression. J Consult Clin Psychol 1996, 64(5):927-935.
• [25]Kopta SM, Howard KI, Lowry JL, Beutler LE: Patterns of symptomatic recovery in psychotherapy. J Consult Clin Psychol 1994, 62(5):1009-1016.
• [26]Franke GH, Hoffmann T, Frommer J: Entspricht die Symptombesserung vier Wochen nach Behandlungsbeginn dem Erfolg in der Ein-Jahres-Katamnese? Z Psychosom Med Psychoanal 2005, 51(4):360-372.
• [27]Liptzin B, Gottlieb GL, Summergrad P: The future of psychiatric services in general hospitals. Am J Psychiatry 2007, 164(10):1468-1472.
• [28]Markowitz JC: A letter from America: rescuing inpatient psychiatry. Evid Based Ment Health 2008, 11(3):68-69.
• [29]Simon J, Pilling S, Burbeck R, Goldberg D: Treatment options in moderate and severe depression: decision analysis supporting a clinical guideline. Br J Psychiatry 2006, 189(6):494-501.
• [30]Guthrie E, Moorey J, Margison F, Barker H, Palmer S, McGrath G, Tomenson B, Creed F: Cost-effectiveness of brief psychodynamic-interpersonal therapy in high utilizers of psychiatric services. Arch Gen Psychiatry 1999, 56(6):519-526.
• [31]Burnand Y, Andreoli A, Kolatte E, Venturini A, Rosset N: Psychodynamic psychotherapy and clomipramine in the treatment of major depression. Psychiatr Serv 2002, 53(5):585-590.
• [32]Simon GE, Khandker RK, Ichikawa L, Operskalski BH: Recovery from depression predicts lower health services costs. J Clin Psychiatry 2006, 67(8):1226-1231.
• [33]Perry JC, Banon E, Ianni F: Effectiveness of psychotherapy for personality disorders. Am J Psychiatry 1999, 156(9):1312-1321.
• [34]Faul F, Erdfelder E, Lang AG, Buchner A: G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39(2):175-191.
• [35]Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 2002, 3(1):5-43.
• [36]Busch F, Rudden M, Shapiro T: Psychodynamic treatment of depression [electronic resource] / Fredric N. Busch, Marie Rudden, Theodore Shapiro. 1st edition. Washington, DC: American Psychiatric Pub; 2004.
• [37]Despland JN, Michel L, de Roten Y: Intervention Psychodynamique Brève (Brief Psychodynamic Intervention). Paris: Elsevier-Masson; 2010.
• [38]Clercq M, Lebigot F: Les traumatismes psychiques. Paris: Masson; 2001.
• [39]Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
• [40]Corruble E, Legrand JM, Duret C, Charles G, Guelfi JD: IDS-C and IDS-sr: psychometric properties in depressed in-patients. J Affect Disord 1999, 56(2–3):95-101.
• [41]Derogatis LR, Spencer MS: The Brief Symptom Inventory (BSI): Administration, scoring, and procedures manual -1. Baltimore: Johns Hopkins University School of Medicine, Clinical Psychometrics Research Unit; 1982.
• [42]Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T: Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 1994, 51(11):849-859.
• [43]Initiative NMG: DIGS (updated version). Bethesda: NIMH; 1995.
• [44]Preisig M, Fenton BT, Matthey ML, Berney A, Ferrero F: Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version. Eur Arch Psychiatry Clin Neurosci 1999, 249(4):174-179.
• [45]Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush AJ, Schatzberg AF, Ninan PT, McCullough JP Jr, Weiss PM, Dunner DL, et al.: Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci 2003, 100(24):14293-14296.
• [46]Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Stokes J, Handelsman L, Medrano M, Desmond D, et al.: Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl 2003, 27(2):169-190.
• [47]Ogrodniczuk JS, Piper WE, Joyce AS: Alexithymia as a predictor of residual symptoms in depressed patients who respond to short-term psychotherapy. Am J Psychother 2004, 58(2):150-161.
• [48]Reicherts M, Casellini D, Duc F, Genoud PA: L' « Ouverture émotionnelle » dans les Troubles de la dépendance et les Troubles de la personnalité. Ann Med Psychol 2007, 165(7):485-491.
• [49]Horowitz LM, Rosenberg SE, Baer BA, Ureno G, Villasenor VS: Inventory of interpersonal problems: psychometric properties and clinical applications. J Consult Clin Psychol 1988, 56(6):885-892.
• [50]Lutz W, Tholen S, Schürch E, Berking M: Die Entwicklung, Validierung und Reliabilität von Kurzformen gängiger psychometrischer Instrumente zur Evaluation des therapeutischen Fortschritts in Psychotherapie und Psychiatrie. Diagnostica 2006, 52(1):11-25.
• [51]Weissman MM, Bothwell S: Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 1976, 33(9):1111-1115.
• [52]OPD: Operationalized psychodynamic diagnosis: OPD-2. Manual of diagnosis and treatment planning. Seattle: Hogrefe & Huber Publishers; 2007.
• [53]Cierpka M, Grande T, Rudolf G, von der Tann M, Staschf M: The operationalized psychodynamic diagnostics system: clinical relevance, reliability and validity. Psychopathology 2007, 40(4):209-220.
• [54]Perry JC, Guelfi JD, Despland J-N, Hanin B: Echelles d'évaluation des mécanismes de défense. Paris: Masson; 2004.
• [55]Hoglend P, Perry JC: Defensive functioning predicts improvement in major depressive episodes. J Nerv Ment Dis 1998, 186(4):238-243.
• [56]Hatcher RL, Gillaspy JA: Development and validation of a revised short version of the working alliance inventory. Psychother Res 2006, 16(1):12-25.
• [57]Blais MA: Development of an inpatient treatment alliance scale. J Nerv Ment Dis 2004, 192(7):487-493.
• [58]Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC: The longitudinal interval follow-up evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987, 44(6):540-548.
• [59]Mergenthaler E, Stigler M: Règles de transcription pour la recherche en psychothérapie. Psychothérapies 1997, 17(2):97-104.
• [60]Kramer U, de Roten Y, Despland J: Do therapists do what they say they will do? A comparison between ideal prototypes and actual practice in several psychotherapeutic approaches. Prat Psychol 2005, 11(4):359-370.
• [61]Ablon JS, Jones EE: Validity of controlled clinical trials of psychotherapy: findings from the NIMH treatment of depression collaborative research program. Am J Psychiatry 2002, 159(5):775-783.
• [62]Boland RJ, Keller MB: Course and outcome of depression. In Handbook of depression. 2nd edition. Edited by Gotlib IH, Hammen CL. New York, NY: Guilford Press; 2009:23-43.
• [63]Jacobson NS, Truax P: Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991, 59(1):12-19.
• [64]Bryk AS, Raudenbush SW: Application of hierarchical linear models to assessing change. Psychol Bull 1987, 101(1):147-158.
• [65]Leichsenring F, Rabung S: Zur Wirksamkeit psychodynamischer Langzeittherapie bei komplexen psychischen Storungen. Der Nervenarzt 2009, 80(11):1343-1349.
• [66]Parker G, Roy K, Eyers K: Cognitive behavior therapy for depression? Choose horses for courses. Am J Psychiatry 2003, 160(5):825-834.